Mechanism
GLP-1 agonists slow gastric emptying, which can lower and delay the peak of pill hormones. For semaglutide the dedicated interaction study found bioequivalence held; for tirzepatide a single-dose study found hormone peaks roughly halved and the label added four-week barrier windows after each dose step. One class, two intensities.
Notes
- On tirzepatide (Mounjaro, Zepbound) with a pill: the label advises a non-oral method or backup contraception for four weeks after starting and after each dose increase.
- On injectable semaglutide (Ozempic, Wegovy) the dedicated study found no loss of pill exposure; a pharmacist conversation covers vomiting or diarrhea windows under your pill brand's missed-dose rules.
- Planning pregnancy: semaglutide is stopped at least two months ahead per the label.